Cite
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
MLA
van Deursen, Anna M. M., et al. “Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 65, no. 5, Sept. 2017, pp. 787–95. EBSCOhost, https://doi.org/10.1093/cid/cix419.
APA
van Deursen, A. M. M., van Houten, M. A., Webber, C., Patton, M., Scott, D. A., Patterson, S., Sidhu, M., Drews, W., Gruber, W. C., Emini, E. A., Grobbee, D. E., Bonten, M. J. M., & Sanders, E. A. M. (2017). Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 65(5), 787–795. https://doi.org/10.1093/cid/cix419
Chicago
van Deursen, Anna M M, Marlies A van Houten, Chris Webber, Michael Patton, Daniel A Scott, Scott Patterson, Mohinder Sidhu, et al. 2017. “Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 65 (5): 787–95. doi:10.1093/cid/cix419.